| Literature DB >> 32435402 |
Eleonora Colombo1, Laura Polito2, Michele Biocotino1, Paola Marzullo1, Mariafrancesca Hyeraci3, Lisa Dalla Via3, Daniele Passarella1.
Abstract
Betulinic acid is validated as a new self-assembly inducer for the formation of nanoparticles (NPs) in combination with different drugs. The target compounds are characterized by the presence of anticancer drugs acting on tubulin dynamics and of a linker that could be a carbon chain or a triazole-based one. Nanoparticles formed are characterized and their biological activity is evaluated.Entities:
Year: 2020 PMID: 32435402 PMCID: PMC7236225 DOI: 10.1021/acsmedchemlett.9b00668
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345